Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Show more
3222 Phoenixville Pike, Malvern, PA, 19355, United States
Market Cap
105.3M
52 Wk Range
$0.80 - $4.85
Previous Close
$1.49
Open
$1.43
Volume
1,052,129
Day Range
$1.40 - $1.54
Enterprise Value
165.2M
Cash
28.36M
Avg Qtr Burn
N/A
Insider Ownership
31.34%
Institutional Own.
64.41%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
